Design and synthesis of novel NO-donor-ferulic acid hybrids as potential antiatherosclerotic drug candidates a

Drug Development Research

Volumn 72, Issue 5, 2011, Pages 405-415

  Li, Nian Guang ^a   Wang, Rong ^a   Shi, Zhi Hao ^b   Tang, Yu Ping ^a   Li, Bao Quan ^a   Wang, Zhen Jiang ^a   Song, Shu Lin ^a   Qian, Li Hua ^a   Wei, Li ^a   Yang, Jian Ping ^a   Yao, Li Juan ^a   Xi, Jun Zuan ^a   Xu, Jia ^a   Feng, Feng ^b   Qian, Da Wei ^a   Duan, Jin Ao ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

atherosclerosis; ferulic acid; nitric oxide donor; nitric oxide release

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 4 [4 (PHENYLSULFONYL) 1,2,5 OXADIAZOL 3 YLOXY]BUTYL 3 (4 HYDROXY 3 METHOXYPHENYL)ACRYLATE; 4 HYDROXYL 3 PHENYLFUROXAN; 4 HYDROXYMETHYL 3 PHENYLSULFONYLFUROXAN; FERULIC ACID; ISOSORBIDE DINITRATE; NITRIC ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; VASODILATATION;

EID: 80052043382     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20442     Document Type: Article

References (27)

1. Andreasen MF, Landbo AK, Christensen LP, Hansen A, Meyer AS,. 2001. Antioxidant effects of phenolic rye (Secale cereale L.) extracts, monomeric hydroxycinnamates, and ferulic acid dehydrodimers on human low-density lipoproteins. J Agric Food Chem 49: 4090-4096. (Pubitemid 32822742)
2. Boschi D, Tron GC, Lazzarato L, Chegaev K, Cena C, Di Stilo A, Giorgis M, Bertinaria M, Fruttero R, Gasco A,. 2006. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties. J Med Chem 49: 2886-2897.
3. Brand-Williams W, Cuvelier ME, Berset C,. 1995. Use of a free radical method to evaluate antioxidant activity. Lebens Wiss Technol 28: 25-30.
4. Buege JA, Aust SD,. 1978. Microsomal lipid peroxidation. Methods Enzymol 52: 302-310.
5. Cena C, Boschi D, Tron GC, Chegaev K, Lazzarato L, Di Stilo A, Aragno M, Fruttero R, Gasco A,. 2004. Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants. Bioorg Med Chem Lett 14: 5971-5974. (Pubitemid 39531253)
6. Cena C, Chegaev K, Balbo S, Lazzarato L, Rolando B, Giorgis M, Marini E, Fruttero R, Gasco A,. 2008. Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties. Bioorg Med Chem 16: 5199-5206. (Pubitemid 351625871)
7. Cherubini A, Vigna GB, Zuliani G, Ruggiero C, Senin U, Fellin R,. 2005. Role of antioxidants in atherosclerosis: epidemiological and clinical update. Curr Pharm Des 11: 2017-2032. (Pubitemid 40766839)
8. Civelli M, Giossi M, Caruso P, Razzetti R, Bergamaschi M, Bongrani S, Gasco A,. 1996. The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363. Br J Pharmacol 118: 923-928. (Pubitemid 26261263)
9. Dziedzic SC, Hudson BJF,. 1984. Phenolic acids and related compounds as antioxidants for edible oils. Food Chem 14: 45-51.
10. Farrar WV,. 1964. The 3,4-bisarenesulphonylfuroxans. J Chem Soc 3: 904-906.
11. Gasco AM, Fruttero R, Sorba G, Gasco A,. 1991. Unsymmetrically substituted furoxans. XIII. Phenylfuroxancarbaldehydes and related compounds. Lieb Ann Chem 11: 1211-1213.
12. Graf E,. 1992. Antioxidant potential of ferulic acid. Free Radic Biol Med 13: 435-448.
13. Hennekens CH,. 1998. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation 97: 1095-1102.
14. Keaney Jr JF, Vita JA,. 1995. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis 38: 129-154.
15. Kelley JL, Mclean EW, Williard KF,. 1977. Synthesis of bis(arylsulphonyl)furoxans from aryl nitromethyl sulfones. J Heterocycl Chem 14: 1415-1416.
16. Kenney WJ, Walsh JA, Davenport DA,. 1961. An acid-catalyzed cleavage of sulfoxides. J Am Chem Soc 83: 4019-4022.
17. Klinger W, Müller D,. 1974. The influence of age on the protein concentration in serum, liver and kidney of rats determined by various methods. Z Versuchstierkd 16: 149-153.
18. 2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids. Biochem Pharmacol 51: 395-402. (Pubitemid 26071172)
19. Medina I, Tombo I, Satué-Gracia MT, German JB, Frankel EN,. 2002. Effects of natural phenolic compounds on the antioxidant activity of lactoferrin in liposomes and oil-in-water emulsions. J Agric Food Chem 50: 2392-2399. (Pubitemid 34275315)
20. Napoli C, de Nigris F, Williams-Ignarro S, Pignalosa O, Sica V, Ignarro LJ,. 2006. Nitric oxide and atherosclerosis: an update. Nitric Oxide 15: 265-279. (Pubitemid 44649284)
21. Ogita H, Liao JK,. 2004. Endothelial function and oxidative stress. Endothelium 11: 123-132. (Pubitemid 39207185)
22. Ohta T, Nakano T, Egashira Y, Sanada H,. 1997. Antioxidant activity of ferulic acid beta-glucuronide in the LDL oxidation system. Biosci Biotechnol Biochem 61: 1942-1943. (Pubitemid 127471799)
23. Praticò D,. 2005. Antioxidants and endothelium protection. Atherosclerosis 181: 215-224. (Pubitemid 41019601)
24. Son S, Lewis BA,. 2002. Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure-activity relationship. J Agric Food Chem 50: 468-472. (Pubitemid 34106663)
25. Sorba G, Medana C, Fruttero R, Cena C, Di Stilo A, Galli U, Gasco A,. 1997. Water soluble furoxan derivatives as NO prodrugs. J Med Chem 40: 463-469. (Pubitemid 27080025)
26. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL,. 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924. (Pubitemid 19101597)
27. Wang H, Gao XD, Zhou GC, Cai L, Yao WB,. 2008. In vitro and in vivo antioxidant activity of aqueous extract from Choerospondias axillaris fruit. Food Chem 106: 888-895. (Pubitemid 47380040)